ANGELALIGN (06699) saw its shares rise over 5% again, continuing a strong upward trend following its earnings report, with cumulative gains reaching 35%. At the time of writing, the stock was up 5.74%, trading at HK$90.25, with a turnover of HK$131 million. On the news front, ANGELALIGN reported revenue of $370 million for 2025, a year-on-year increase of 37.8%. The company achieved a net profit of $26.3 million, surging 163.0% compared to the previous year, while its adjusted net profit reached $43.77 million, up 62.99% year-on-year. The total number of cases completed for the year was 532,400, representing a 48.1% increase. Notably, ANGELALIGN has received positive ratings from several institutions after its results. Huafu Securities stated that, considering the significant effectiveness of the company's domestic market penetration strategy and the continued high growth in overseas markets, it has raised its profit forecasts. Huachuang Securities noted that looking ahead to 2026, as overseas losses narrow further or even turn to profit and domestic profits grow steadily, the company's overall profitability is expected to continue improving.